Bruce Trock
Johns Hopkins University
H-index: 92
North America-United States
Top articles of Bruce Trock
The association of subspecialty and sex with industry payments to internal medicine physicians who recently completed training
Journal of general internal medicine
2024/1
MP33-12 INDUSTRY PAYMENTS TO UROLOGISTS IN 2022: DESCRIPTIVE ANALYSIS OF THE OPEN PAYMENTS PROGRAM DATABASE
The Journal of Urology
2024/5
MP16-14 A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NAÏVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
The Journal of Urology
2024/5
Nirmish Singla
H-Index: 19
Bruce Trock
H-Index: 48
A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder
The Journal of Urology
2024/4/23
Nirmish Singla
H-Index: 19
Bruce Trock
H-Index: 48
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
JAMA oncology
2024/4/18
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models
The Prostate
2024/4/15
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
European Urology Oncology
2024/4/3
ASSOCIATION BETWEEN DIETARY NUTRIENTS AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
Urologic Oncology: Seminars and Original Investigations
2024/3/1
ERAS FOR AMBULATORY TURBT: ENHANCING BLADDER CANCER CARE (EMBRACE) RANDOMIZED CONTROLLED TRIAL
Urologic Oncology: Seminars and Original Investigations
2024/3/1
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Scientific reports
2024/1/17
Likelihood of sampling prostate cancer at systematic biopsy as a function of gland volume and number of cores
Prostate Cancer and Prostatic Diseases
2024/1/6
Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer
The Journal of Pathology
2024/1
Risk of biochemical recurrence in patients with Grade Group 1 prostate cancer with extraprostatic extension treated with radical prostatectomy
2023/12/27
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification
Urologic Oncology: Seminars and Original Investigations
2023/11/1
Industry payments received by residents during training
JAMA Network Open
2023/10/2
Machine Learning for the Prediction of Adverse Pathological Outcomes in Patients Treated with Radical Prostatectomy
International journal of radiation oncology, biology, physics
2023/10/1
Predicting prostate cancer molecular subtype with deep learning on histopathologic images
Modern Pathology
2023/10/1
Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer
European Urology Oncology
2023/10/1
MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
Prostate cancer and prostatic diseases
2023/9
ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins
Modern Pathology
2023/7/1